Literature DB >> 7569737

Elimination of the non-ionic X-ray contrast media iodixanol and iohexol in patients with severely impaired renal function.

J O Nossen1, J A Jakobsen, P Kjaersgaard, E Andrew, P B Jacobsen, K J Berg.   

Abstract

Iodixanol (Visipaque) and iohexol (Omnipaque) are dimeric and monomeric, respectively, non-ionic X-ray contrast media (CM), with well-characterized pharmacokinetics in healthy volunteers. This study was undertaken to study the pharmacokinetics of the contrast media in patients with severely impaired renal function. A total of 16 patients referred for preoperative abdominal angiography were randomized to form two groups of eight patients, receiving either iodixanol 320 mgI ml-1 or iohexol 350 mgI ml-1. Urine and faeces were sampled before the examination and collected quantitatively for five days afterwards, and blood samples were drawn frequently. The concentrations of iodine and contrast medium in urine and in serum, and the amount of iodine in faeces were determined. Mean baseline creatinine clearance was 13.6 and 9.9 ml min-1 1.73 m-2 in the iodixanol and iohexol groups, respectively. Patients in the iodixanol group received on average 0.34 gI per kg bodyweight (bw) and those in the iohexol group 0.39 gI per kg bw. The semilogarithmic plots of serum concentration of CM vs. time indicated elimination according to a two-compartment model. The mean elimination half-life was 23.0 h for iodixanol and 27.2 h for iohexol, and the mean apparent volume of distribution was similar for the two CM, ranging from 0.20 to 0.30 1 per kg bw. Mean plasma clearance of iodixanol was 10.4 ml min-1 1.73 m-2 and 6.9 ml min-1 1.73 m-2 for iohexol, whereas the mean renal clearances were 8.7 and 6.1 ml min-1 1.73 m-2, respectively. Mean faecal recovery was 8.2% for iodixanol and 6.1% for iohexol, and the respective figures for that in urine were 76.1 and 74.8%. Renal clearance of radiolabelled iothalamate, a marker of glomerular filtration rate (GFR), measured simultaneously, indicated that both CM were eliminated by the kidneys by glomerular filtration only. Thus, both media are suitable as GFR markers.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7569737     DOI: 10.3109/00365519509104972

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  6 in total

Review 1.  Biomarkers in chronic kidney disease, from kidney function to kidney damage.

Authors:  Salvador Lopez-Giacoman; Magdalena Madero
Journal:  World J Nephrol       Date:  2015-02-06

Review 2.  An overview of glomerular filtration rate testing in dogs and cats.

Authors:  Vanessa E Von Hendy-Willson; Barrak M Pressler
Journal:  Vet J       Date:  2010-06-11       Impact factor: 2.688

3.  Determination of glomerular filtration rate with Visipaque in patients with severely reduced renal function.

Authors:  P Kjaersgaard; J A Jakobsen; J O Nossen; K J Berg
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

4.  Excessively High Hydration Volume May Not Be Associated With Decreased Risk of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention in Patients With Renal Insufficiency.

Authors:  Yong Liu; Hualong Li; Shiqun Chen; Jiyan Chen; Ning Tan; Yingling Zhou; Yuanhui Liu; Piao Ye; Peng Ran; Chongyang Duan; Pingyan Chen
Journal:  J Am Heart Assoc       Date:  2016-05-27       Impact factor: 5.501

Review 5.  Mechanisms of contrast-induced nephropathy reduction for saline (NaCl) and sodium bicarbonate (NaHCO3).

Authors:  W Patrick Burgess; Phillip J Walker
Journal:  Biomed Res Int       Date:  2014-04-15       Impact factor: 3.411

6.  Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 1: How to measure glomerular filtration rate with iohexol?

Authors:  Pierre Delanaye; Natalie Ebert; Toralf Melsom; Flavio Gaspari; Christophe Mariat; Etienne Cavalier; Jonas Björk; Anders Christensson; Ulf Nyman; Esteban Porrini; Giuseppe Remuzzi; Piero Ruggenenti; Elke Schaeffner; Inga Soveri; Gunnar Sterner; Bjørn Odvar Eriksen; Sten-Erik Bäck
Journal:  Clin Kidney J       Date:  2016-08-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.